Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novoste CEO’s Challenge: Stabilize Brachy Biz Or Ink Merger While Cash Lasts

This article was originally published in The Gray Sheet

Executive Summary

Novoste's cash burn rate of about $1 mil. per month puts pressure on management either to acquire a growth platform to augment flagging Beta-Cath vascular brachytherapy revenue or sell the company

You may also be interested in...



Novoste To Merge With ONI Medical, Exits Once-Promising Brachy Biz

Novoste will attempt to divest its Beta-Cath vascular brachytherapy (VBT) business to one of several interested parties prior to the firm's merger with ONI Medical, likely to close in the third quarter

Novoste To Merge With ONI Medical, Exits Once-Promising Brachy Biz

Novoste will attempt to divest its Beta-Cath vascular brachytherapy (VBT) business to one of several interested parties prior to the firm's merger with ONI Medical, likely to close in the third quarter

Digene Stock Rebound Could Continue In 2005; OTC Index Ahead 23%

Digene's increased focus on physician detailing for its DNAwithPap human papillomavirus test, coupled with plans for consumer advertising, could allow the firm to exceed recently revised growth expectations

Related Content

UsernamePublicRestriction

Register

MT021150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel